2.Reversible phosphorylation of the 26S proteasome.
Xing GUO ; Xiuliang HUANG ; Mark J CHEN
Protein & Cell 2017;8(4):255-272
The 26S proteasome at the center of the ubiquitin-proteasome system (UPS) is essential for virtually all cellular processes of eukaryotes. A common misconception about the proteasome is that, once made, it remains as a static and uniform complex with spontaneous and constitutive activity for protein degradation. Recent discoveries have provided compelling evidence to support the exact opposite insomuch as the 26S proteasome undergoes dynamic and reversible phosphorylation under a variety of physiopathological conditions. In this review, we summarize the history and current understanding of proteasome phosphorylation, and advocate the idea of targeting proteasome kinases/phosphatases as a new strategy for clinical interventions of several human diseases.
Animals
;
Humans
;
Phosphoprotein Phosphatases
;
genetics
;
metabolism
;
Phosphorylation
;
genetics
;
Proteasome Endopeptidase Complex
;
genetics
;
metabolism
;
Protein Kinases
;
genetics
;
metabolism
3.Molecular mechanism of ORFV intervention strategies based on the UPS of host cell: a review.
Yong-Zhong YU ; Chun-Yu TONG ; Bai-Fen SONG ; Hong-Boi AN ; Li-Yun YU ; Li YU ; Yu-Dong CUI
Chinese Journal of Virology 2013;29(6):662-666
In order to compete the antiviral effects of the host cell in the process of infection, ORFV(known as Orf virus) relies on a series of functional genes developed through long-term population evolution, such as interferon resistance genes, Bcl-2 protein genes and cell cycle inhibitor gene and so on, with these weapons this virus is able to effectively counteract immune clearance and immune regulation from a host cell. Concurrently, ORFV also focuses on exploiting signal transduction pathways of the ubiquitin-proteasome system(UPS), circumvents the intracellular signal transduction and CD8+ T activation, for shielding virus particles towards maturation and releasing outside. This review introduced inner link between the UPS of host cell and intervention mechanism by virus, and analyzed the key roles of certains components in UPS, these all together showed the evolution tendency of ORFV that was involved in the designing of inhibition to immune response and for intracellular immune escape upon the selection pressure in host cell infected.
Animals
;
Ecthyma, Contagious
;
enzymology
;
virology
;
Host-Pathogen Interactions
;
Humans
;
Orf virus
;
genetics
;
physiology
;
Proteasome Endopeptidase Complex
;
metabolism
;
Ubiquitin
;
metabolism
4.DSSylation, a novel protein modification targets proteins induced by oxidative stress, and facilitates their degradation in cells.
Yinghao ZHANG ; Fang-Mei CHANG ; Jianjun HUANG ; Jacob J JUNCO ; Shivani K MAFFI ; Hannah I PRIDGEN ; Gabriel CATANO ; Hong DANG ; Xiang DING ; Fuquan YANG ; Dae Joon KIM ; Thomas J SLAGA ; Rongqiao HE ; Sung-Jen WEI
Protein & Cell 2014;5(2):124-140
Timely removal of oxidatively damaged proteins is critical for cells exposed to oxidative stresses; however, cellular mechanism for clearing oxidized proteins is not clear. Our study reveals a novel type of protein modification that may play a role in targeting oxidized proteins and remove them. In this process, DSS1 (deleted in split hand/split foot 1), an evolutionally conserved small protein, is conjugated to proteins induced by oxidative stresses in vitro and in vivo, implying oxidized proteins are DSS1 clients. A subsequent ubiquitination targeting DSS1-protein adducts has been observed, suggesting the client proteins are degraded through the ubiquitin-proteasome pathway. The DSS1 attachment to its clients is evidenced to be an enzymatic process modulated by an unidentified ATPase. We name this novel protein modification as DSSylation, in which DSS1 plays as a modifier, whose attachment may render target proteins a signature leading to their subsequent ubiquitination, thereby recruits proteasome to degrade them.
Free Radicals
;
metabolism
;
HeLa Cells
;
Humans
;
Oxidation-Reduction
;
Oxidative Stress
;
genetics
;
Proteasome Endopeptidase Complex
;
genetics
;
metabolism
;
Protein Binding
;
Protein Modification, Translational
;
genetics
;
Ubiquitin
;
metabolism
;
Ubiquitination
;
genetics
5.Expression of genes psma6 and slc25a4 in patients with acute monocytic leukemia.
Yin-Xia CHEN ; Wen-Ping WANG ; Peng-Yu ZHANG ; Wang-Gang ZHANG ; Jie LIU ; Xiao-Rong MA
Journal of Experimental Hematology 2009;17(5):1168-1173
The aim of this study was to investigate the expression levels of genes psma6 and slc25a4 in bone marrow of patients with acute monocytic leukemia and their correlation with clinical features and prognosis. The expression levels of genes psma6 and slc25a4 in AML-M5 leukemia cells, normal blood cells and non-leukemia cells were detected by real-time quantitative RT-PCR and compared each other. The expression levels of psma6-encoding protein P27K was assayed by using immunohistochemistry method. The results showed that the expression levels of psma6 mRNA in AML-M5 leukemia cells was lower than that in non AML-M5 leukemia cells, non-leukemia cells and normal blood cells. The results obtained by immunohistochemistry assay were consistent with above-mentioned results. The expression level of psma6 in AML-M5 patients with complete remission was higher than that in AML-M5 patients without remission. The expression level of P27K protein in AML-M5 and AL correlated to leukocyte count in peripheral blood and LDH content. The overexpression of slc25a4 mRNA was found in AML-M5, but there was no significant difference in slc25a4 mRNA expression between the patients with complete remission and those without remission. It is concluded that the expression level of psma6 is probably a new prognostic indicator of acute monocytic leukemia, slc25a4 may be a novel gene of antigen associated with acute monocytic leukemia.
Adenine Nucleotide Translocator 1
;
genetics
;
metabolism
;
Adult
;
Bone Marrow
;
metabolism
;
Female
;
Humans
;
Leukemia, Monocytic, Acute
;
genetics
;
metabolism
;
Male
;
Proteasome Endopeptidase Complex
;
genetics
;
metabolism
6.Mechanism of heat shock protein 90 for regulating 26S proteasome in hyperthermia.
Qing-Rong MA ; Pei-Zhi YU ; Fan ZHANG ; Yu-Qi LI ; Shu YANG ; Xian-Yi MO ; Kai-Lan MO ; Ying DING ; Si-Ze CHEN
Journal of Southern Medical University 2016;37(4):537-541
OBJECTIVETo investigate the mechanism by which heat shock protein 90 (HSP90) regulates 26S proteasome in hyperthermia.
METHODSHyperthermic HepG2 cell models established by exposure of the cells to 42 degrees celsius; for 3, 6, 12, and 24 h were examined for production of reactive oxygen species (ROS) and cell proliferation, and the changes in Hsp90α and 26S proteasome were analyzed.
RESULTSROS production in the cells increased significantly after hyperthermia (F=28.958, P<0.001), and the cell proliferation was suppressed progressively as the heat exposure time extended (F=621.704, P<0.001). Hyperthermia up-regulated Hsp90α but decreased the expression level (F=164.174, P<0.001) and activity (F=133.043, P<0.001) of 26S proteasome. The cells transfected with a small interfering RNA targeting Hsp90α also showed significantly decreased expression of 26S proteasome (F=180.231, P<0.001).
CONCLUSIONThe intracellular ROS production increases as the hyperthermia time extends. Heat stress and ROS together cause protein denature, leading to increased HSP90 consumption and further to HSP90 deficiency for maintaining 26S proteasome assembly and stability. The accumulation of denatured protein causes unfolded protein reaction in the cells to eventually result in cell death.
HSP90 Heat-Shock Proteins ; metabolism ; Hep G2 Cells ; Hot Temperature ; Humans ; Proteasome Endopeptidase Complex ; metabolism ; RNA, Small Interfering ; genetics ; Reactive Oxygen Species ; metabolism ; Up-Regulation
7.Expression, purification of proteasome subunit PSMB1 and application in screening of possible proteasome inhibitors.
Cuiying FAN ; Lixing FENG ; Dongmei ZHANG ; Suna PAN ; Xuan LIU ; De'an GUO ; Jinling FAN
Chinese Journal of Biotechnology 2012;28(2):233-242
Proteasome is a multi-subunit protease complex in eukaryocytes, and plays an important role in ubiquitin-proteosome pathway. Recombinant proteasome can be used to screen proteasome inhibitors. In this study, recombinant plasmid of pET28a-PSMB1 was constructed by inserting human proteasome catalytic subunit (PSMB1) cDNA (726 bp) into the prokaryotic expression vector pET28a(+), and transforming the plasmid into E. coli BL21(DE3) cells for expression. After overnight induction (1 mmol/L IPTG, 20 degrees C), an expected protein band with molecular weight of 27 kDa was observed on SDS-PAGE gel. The recombinant protein was then purified through affinity chromatography, and the purity is more than 95%. The amino acid sequence of the recombinant protein was validated by NanoLC-MS/MS. The data from in vitro BIAcore analysis showed that the recombinant PSMB1 could bind to celastrol. The binding affinity between PSMB1 and 10 micromol/L celastrol was more than 27RU.
Binding Sites
;
Escherichia coli
;
genetics
;
metabolism
;
Genetic Vectors
;
genetics
;
Humans
;
Proteasome Endopeptidase Complex
;
biosynthesis
;
genetics
;
isolation & purification
;
Proteasome Inhibitors
;
isolation & purification
;
Recombinant Proteins
;
biosynthesis
;
genetics
;
metabolism
;
Triterpenes
;
metabolism
;
Ubiquitin
8.APP and APLP1 are degraded through autophagy in response to proteasome inhibition in neuronal cells.
Fangfang ZHOU ; Theo VAN LAAR ; Huizhe HUANG ; Long ZHANG
Protein & Cell 2011;2(5):377-383
Amyloid beta (Aβ) precursor protein (APP) is a key protein in the pathogenesis of Alzheimer's disease (AD). Both APP and its paralogue APLP1 (amyloid beta precursor-like protein 1) have multiple functions in cell adhesion and proliferation. Previously it was thought that autophagy is a novel beta-amyloid peptide (Aβ)-generating pathway activated in AD. However, the protein proteolysis of APLP1 is still largely unknown. The present study shows that APLP1 is rapidly degraded in neuronal cells in response to stresses, such as proteasome inhibition. Activation of the endoplasmic reticulum (ER) stress by proteasome inhibitors induces autophagy, causing reduction of mature APLP1/APP. Blocking autophagy or JNK stress kinase rescues the protein expression for both APP and APLP1. Therefore, our results suggest that APP/APLP1 is degraded through autophagy and the APLP1 proteolysis is mainly mediated by autophagy-lysosome pathway.
Amyloid beta-Protein Precursor
;
genetics
;
metabolism
;
Animals
;
Autophagy
;
Cell Line
;
Endoplasmic Reticulum
;
metabolism
;
JNK Mitogen-Activated Protein Kinases
;
antagonists & inhibitors
;
metabolism
;
Leupeptins
;
pharmacology
;
Mice
;
Neurons
;
cytology
;
metabolism
;
Proteasome Endopeptidase Complex
;
metabolism
;
Proteasome Inhibitors
;
Protein Stability
;
Rats
9.Mice-lacking LMP2, immuno-proteasome subunit, as an animal model of spontaneous uterine leiomyosarcoma.
Takuma HAYASHI ; Akiko HORIUCHI ; Kenji SANO ; Nobuyoshi HIRAOKA ; Yae KANAI ; Tanri SHIOZAWA ; Susumu TONEGAWA ; Ikuo KONISHI
Protein & Cell 2010;1(8):711-717
Uterine tumors are the most common type of gynecologic neoplasm. Uterine leiomyosarcoma (LMS) is rare, accounting for 2% to 5% of tumors of the uterine body. Uterine LMS develops more often in the muscle tissue layer of the uterine body than in the uterine cervix. The development of gynecologic tumors is often correlated with female hormone secretion; however, the development of uterine LMS is not substantially correlated with hormonal conditions, and the risk factors are not yet known. Radiographic evaluation combined with PET/CT can be useless in the diagnosis and surveillance of uterine LMS. Importantly, a diagnostic biomarker, which distinguishes malignant LMS and benign tumor leiomyoma (LMA) is yet to be established. Accordingly, it is necessary to analyze risk factors associated with uterine LMS in order to establish a method of treatment. LMP2-deficient mice spontaneously develop uterine LMS, with a disease prevalence of ∼40% by 14 months of age. It is therefore of interest whether human uterine LMS shows a loss of LMP2 expression. We found LMP2 expression is absent in human LMS, but present in human LMA. Therefore, defective LMP2 expression may be one of the risk factors for LMS. LMP2 is potentially a diagnostic biomarker for uterine LMS, and gene therapy with LMP2-encording DNA may be a new therapeutic approach.
Animals
;
Biomarkers, Tumor
;
biosynthesis
;
genetics
;
Cysteine Endopeptidases
;
biosynthesis
;
genetics
;
Down-Regulation
;
Female
;
Gene Deletion
;
Humans
;
Interferon Regulatory Factor-1
;
biosynthesis
;
genetics
;
Leiomyoma
;
metabolism
;
Leiomyosarcoma
;
diagnosis
;
genetics
;
metabolism
;
Mice
;
Mice, Knockout
;
Proteasome Endopeptidase Complex
;
metabolism
;
Uterine Neoplasms
;
diagnosis
;
genetics
;
metabolism
10.Cellular immunotoxicity of rAAV gene medicine and possible solutions.
Yong DIAO ; Qi-zhao WANG ; Wei-dong XIAO ; Rui-an XU
Acta Pharmaceutica Sinica 2010;45(9):1071-1077
Gene medicine based on recombinant adeno-associated virus (rAAV) vector has rapidly become the prior-choose reagent for gene therapy, since it had been shown that the rAAV was able to stably express many genes in vivo without detectable side-effect. However, recent findings of CTL immune responses to AAV capsid in a clinical trial highlighted a new issue regarding safety that previously was not identified in animal studies. Obviously it is so important to understand the interaction of rAAV with the immune system in details for the safety and success of rAAV gene medicine. In this review we evaluate several current hypotheses aiming to explain the cellular immunotoxicity, also analysis the current findings including the presentation kinetics of the capsid antigen and the activation of CTL. Focusing on the key steps of the immune response several solutions are proposed, including immunosuppression, optimization of vector and improvement of purity, in order to insure clinical safety and efficacy of rAAV.
Animals
;
Capsid
;
immunology
;
Dependovirus
;
genetics
;
Genetic Therapy
;
Genetic Vectors
;
adverse effects
;
immunology
;
Humans
;
Immune Tolerance
;
Immunity, Cellular
;
Immunosuppressive Agents
;
pharmacology
;
Proteasome Endopeptidase Complex
;
metabolism
;
Proteasome Inhibitors
;
Recombinant Proteins
;
adverse effects
;
immunology
;
T-Lymphocytes, Cytotoxic
;
immunology